Delivery Order SPE2DB22D1106-SPE2DB25FEJF9

Award Date 4/17/25
Potential Completion Date 5/8/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71 and a period of performance through April 2, 2025. The contract is a firm fixed-price type and was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $2,652.57 and a completion date of June 13, 2025. The contract is a Firm Fixed Price type, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71 and a period of performance through April 28, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a medical product, with a ceiling value of $21,220.56 and a completion date of April 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,262.85, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of July 14, 2025. The contract is a Firm Fixed Price agreement and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,830.84, is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through May 5, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The award has a ceiling value of $31,830.84 and a completion date of May 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of IMFINZI 500 MG/10 ML VIAL 10ML. The contract has a ceiling value of $15,915.42 and a performance period through May 9, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $7,957.71. The contract is a firm fixed-price delivery order, with a period of performance through June 3, 2025. The award is not associated with a set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a firm fixed price ceiling value of $2,652.57. The award date is May 22, 2025, and the ultimate completion date is June 13, 2025. This is not a set-aside contract, indicating open competition....
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEJF9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $15,915.42 and a performance period ending on May 8, 2025. This contract is not set aside and was awarded on April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for federal agencies, including the Defense Health Agency and U.S. Coast Guard, through December 2026.

Generated 7/17/25, 2:22 PM